4D Molecular Therapeutics Announces Pricing of Upsized Public Offering of Common Stock streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
EMERYVILLE, Calif., May 04, 2023 4D Molecular Therapeutics, Inc. , a clinical-stage biotherapeutics company harnessing the power of directed evolution for genetic medicines targeting large. | May 4, 2023
4D Molecular Therapeutics Inc (FDMT) Announces Proposed $100M Share Offering streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating) – Analysts at SVB Leerink raised their FY2024 earnings per share estimates for shares of 4D Molecular Therapeutics in a report issued on Thursday, April 13th. SVB Leerink analyst M. Foroohar now expects that the company will post earnings of ($2.48) per share for the year, up […]
Vaxart (NASDAQ:VXRT – Get Rating) and 4D Molecular Therapeutics (NASDAQ:FDMT – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings. Risk and Volatility Vaxart has a beta of 0.82, […]